March 21, 2019

Merit's Embosphere Microspheres Receive Expanded Indication to Control Bleeding/Hemorrhaging in the Peripheral Vasculature

March 22, 2019—Merit Medical Systems, Inc. announced the FDA clearance of an expanded indication for its Embosphere microspheres for the embolization of blood vessels to occlude blood flow in the peripheral vasculature to control bleeding or hemorrhaging. It is the first spherical embolic device to be cleared for this use.

According to the company, Embosphere microspheres have now received more indications for use than any other spherical embolic on the market. With this approval, Embosphere microspheres are now indicated for use in embolization of arteriovenous malformations, hypervascular tumors, symptomatic uterine fibroids, prostatic arteries for the relief of symptoms related to benign prostatic hyperplasia, and for controlling bleeding/hemorrhaging in the peripheral vasculature.

Subscribe to our weekly newsletter.

Stay informed on the week's top stories including literature summaries, device approvals, guideline changes, and more. Plus, get our latest issues & supplements delivered to your inbox each month.

March 21, 2019

Merit's Embosphere Microspheres Receive Expanded Indication to Control Bleeding/Hemorrhaging in the Peripheral Vasculature

Current Issue

Keep In Touch